Literature DB >> 17576760

Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.

S Arjcharoen1, C Wikraiphat, M Pudla, K Limposuwan, D E Woods, S Sirisinha, P Utaisincharoen.   

Abstract

Burkholderia pseudomallei is a facultative intracellular gram-negative bacterium that can survive and multiply inside macrophages. One of the mechanisms by which B. pseudomallei escapes macrophage killing is by interfering with the expression of inducible nitric oxide synthase (iNOS). However, the bacterial components that modulate antimicrobial activity of the macrophage have not been fully elucidated. In the present study, we demonstrated that B. pseudomallei strain SRM117, a lipopolysaccharide (LPS) mutant that lacks the O-antigenic polysaccharide moiety, was more susceptible to macrophage killing during the early phase of infection than the parental wild-type strain (1026b). Unlike the wild type, the LPS mutant could readily stimulate Y701-STAT-1 phosphorylation (pY701-STAT-1) and interferon-regulatory factor 1 (IRF-1) expression, both of which are essential transcription factors of iNOS. Neutralizing antibody against beta interferon was able to inhibit the phosphorylation of Y701-STAT-1 and the expression of IRF-1 and iNOS, all of which resulted in an increased rate of intracellular replication. These data suggest that the O-antigenic polysaccharide moiety of B. pseudomallei modulates the host cell response, which in turn controls the intracellular fate of B. pseudomallei inside macrophages.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576760      PMCID: PMC1951188          DOI: 10.1128/IAI.00285-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

Review 1.  Current studies on the pathogenesis of melioidosis.

Authors:  D E Woods; D DeShazer; R A Moore; P J Brett; M N Burtnick; S L Reckseidler; M D Senkiw
Journal:  Microbes Infect       Date:  1999-02       Impact factor: 2.700

2.  Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading.

Authors:  W Kespichayawattana; S Rattanachetkul; T Wanun; P Utaisincharoen; S Sirisinha
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei.

Authors:  L E Bryan; S Wong; D E Woods; D A Dance; W Chaowagul
Journal:  Can J Infect Dis       Date:  1994-07

4.  Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture.

Authors:  V S Harley; D A Dance; B S Drasar; G Tovey
Journal:  Microbios       Date:  1998

Review 5.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.

Authors:  Katrin Breitbach; Sonja Klocke; Thomas Tschernig; Nico van Rooijen; Ulrich Baumann; Ivo Steinmetz
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

7.  Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing.

Authors:  P Utaisincharoen; N Tangthawornchaikul; W Kespichayawattana; P Chaisuriya; S Sirisinha
Journal:  Microbiol Immunol       Date:  2001       Impact factor: 1.955

8.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Isolation and characterization of Pseudomonas pseudomallei flagellin proteins.

Authors:  P J Brett; D C Mah; D E Woods
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Role of interferon regulatory factor 1 in induction of nitric oxide synthase.

Authors:  E Martin; C Nathan; Q W Xie
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  27 in total

1.  Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection.

Authors:  Katie L Propst; Ryan M Troyer; Lisa M Kellihan; Herbert P Schweizer; Steven W Dow
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway.

Authors:  M Pudla; K Limposuwan; P Utaisincharoen
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

3.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

4.  Sterile-α- and armadillo motif-containing protein inhibits the TRIF-dependent downregulation of signal regulatory protein α to interfere with intracellular bacterial elimination in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  Pankaj Baral; Pongsak Utaisincharoen
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

5.  Caspase-4 Mediates Restriction of Burkholderia pseudomallei in Human Alveolar Epithelial Cells.

Authors:  Chanya Srisaowakarn; Matsayapan Pudla; Marisa Ponpuak; Pongsak Utaisincharoen
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

6.  Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei.

Authors:  Jessica Jones-Carson; James R Laughlin; Amanda L Stewart; Martin I Voskuil; Andrés Vázquez-Torres
Journal:  Nitric Oxide       Date:  2012-04-10       Impact factor: 4.427

7.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

8.  Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Vidhya Novem; Guanghou Shui; Dongling Wang; Anne K Bendt; Siew Hoon Sim; Yichun Liu; Tuck Weng Thong; Suppiah Paramalingam Sivalingam; Eng Eong Ooi; Markus R Wenk; Gladys Tan
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

9.  Involvement of signal regulatory protein α, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages.

Authors:  Pankaj Baral; Pongsak Utaisincharoen
Journal:  Infect Immun       Date:  2012-09-17       Impact factor: 3.441

10.  Burkholderia pseudomallei induces IL-23 production in primary human monocytes.

Authors:  Panthong Kulsantiwong; Matsayapan Pudla; Jitrada Boondit; Chanthiwa Wikraiphat; Susanna J Dunachie; Narisara Chantratita; Pongsak Utaisincharoen
Journal:  Med Microbiol Immunol       Date:  2015-11-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.